Preclinical Research

(Image: Getty/utah778)

News in brief

GSK signs R&D agreement with India-based CRO Syngene

By Melissa Fassbender

Syngene International has signed a multiyear agreement with GSK through which the companies will focus on accelerating the discovery of new drug candidates using the CRO’s discovery services platforms.